Laura Cortesi

7.8k total citations · 1 hit paper
172 papers, 2.9k citations indexed

About

Laura Cortesi is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Laura Cortesi has authored 172 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 62 papers in Oncology and 55 papers in Cancer Research. Recurrent topics in Laura Cortesi's work include BRCA gene mutations in cancer (63 papers), Breast Cancer Treatment Studies (30 papers) and Cancer Genomics and Diagnostics (27 papers). Laura Cortesi is often cited by papers focused on BRCA gene mutations in cancer (63 papers), Breast Cancer Treatment Studies (30 papers) and Cancer Genomics and Diagnostics (27 papers). Laura Cortesi collaborates with scholars based in Italy, United States and France. Laura Cortesi's co-authors include Angela Toss, Massimo Federico, Hope S. Rugo, Christian Jackisch, Giovanni Grandi, Alessandro Nobili, Angelo Cagnacci, Mauro Tettamanti, Elisabetta Razzaboni and Elisabetta De Matteis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Laura Cortesi

166 papers receiving 2.8k citations

Hit Papers

An Overview of PARP Inhibitors for the Treatment of Breas... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An Overview of PARP Inhibitors for the Treatment of Breast Cancer
    2021 241 citations Laura Cortesi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Cortesi Italy 28 1.0k 885 753 712 395 172 2.9k
Therese B. Bevers United States 28 1.8k 1.7× 1.3k 1.5× 584 0.8× 1.0k 1.4× 690 1.7× 117 3.9k
Franco Lumachi Italy 33 1.3k 1.3× 400 0.5× 601 0.8× 777 1.1× 352 0.9× 198 3.8k
Reena S. Cecchini United States 20 1.8k 1.7× 1.1k 1.2× 393 0.5× 959 1.3× 370 0.9× 49 2.9k
Larissa A. Korde United States 27 1.7k 1.7× 810 0.9× 764 1.0× 1.0k 1.5× 681 1.7× 81 3.7k
William J. Huster United States 21 1.2k 1.2× 1.5k 1.7× 795 1.1× 245 0.3× 309 0.8× 45 3.6k
D Grady United States 15 1.3k 1.2× 2.3k 2.6× 503 0.7× 514 0.7× 590 1.5× 22 4.3k
Jonine L. Bernstein United States 33 1.1k 1.1× 1.4k 1.6× 875 1.2× 1.4k 2.0× 550 1.4× 138 3.7k
Sara Wedrén Sweden 27 696 0.7× 616 0.7× 903 1.2× 478 0.7× 242 0.6× 53 2.5k
Matteo Puntoni Italy 33 1.8k 1.8× 668 0.8× 1.7k 2.2× 1.2k 1.7× 256 0.6× 139 4.8k
Christine D. Berg United States 18 1.2k 1.2× 727 0.8× 422 0.6× 768 1.1× 367 0.9× 43 2.5k

Countries citing papers authored by Laura Cortesi

Since Specialization
Citations

This map shows the geographic impact of Laura Cortesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Cortesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Cortesi more than expected).

Fields of papers citing papers by Laura Cortesi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Cortesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Cortesi. The network helps show where Laura Cortesi may publish in the future.

Co-authorship network of co-authors of Laura Cortesi

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Cortesi. A scholar is included among the top collaborators of Laura Cortesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Cortesi. Laura Cortesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carbone, Alessio, Martino Oliva, Matteo Puntoni, et al.. (2025). Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer. JNCI Journal of the National Cancer Institute.
2.
3.
Fabi, Alessandra, Laura Cortesi, Simona Duranti, et al.. (2024). Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2. Critical Reviews in Oncology/Hematology. 201. 104431–104431.
4.
Freyer, Gilles, Noelia Martínez-Jáñez, Bożena Kukiełka-Budny, et al.. (2024). Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study. The Breast. 74. 103681–103681. 1 indexed citations
5.
Donati, Benedetta, Francesca Reggiani, Federica Torricelli, et al.. (2023). Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancer Immunology Research. 12(1). 120–134. 10 indexed citations
6.
Toss, Angela, Luca Moscetti, Enza Di Palma, et al.. (2023). Management ofPALB2‐associated breast cancer: A literature review and case report. SHILAP Revista de lepidopterología. 11(8). e7747–e7747. 7 indexed citations
7.
Barbieri, Elena, Marta Venturelli, Federico Piacentini, et al.. (2023). Personalized Systemic Therapies in Hereditary Cancer Syndromes. Genes. 14(3). 684–684. 7 indexed citations
8.
Tenedini, Elena, Simonetta Piana, Angela Toss, et al.. (2022). Constitutional Mosaicism: A Critical Issue in the Definition of BRCA-Inherited Cancer Risk. JCO Precision Oncology. 6(6). e2200138–e2200138. 3 indexed citations
9.
Miglietta, Federica, Michela Cinquini, Maria Vittoria Dieci, et al.. (2022). PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology. The Breast. 66. 293–304. 7 indexed citations
10.
Toss, Angela, Elena Tenedini, Marta Venturelli, et al.. (2021). Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers. Genes. 12(5). 616–616. 20 indexed citations
11.
Toss, Angela, Elena Tenedini, Alessandra Bologna, et al.. (2021). The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study. Diagnostics. 11(3). 565–565. 5 indexed citations
12.
Parenti, Sandra, Claudio Rabacchi, Marco Marino, et al.. (2021). Characterization of New ATM Deletion Associated with Hereditary Breast Cancer. Genes. 12(2). 136–136. 6 indexed citations
13.
Tenedini, Elena, Marco Marino, Lucia Artuso, et al.. (2021). Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework. Diagnosis. 9(1). 115–122. 3 indexed citations
14.
Toss, Angela, Eleonora Molinaro, Marta Venturelli, et al.. (2020). BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy. Cancers. 12(5). 1252–1252. 19 indexed citations
15.
Mannucci, Pier Mannuccio, Alessandro Nobili, Emanuela Marchesini, et al.. (2018). Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age‐matched controls. Haemophilia. 24(5). 726–732. 6 indexed citations
16.
Omarini, Claudia, Giorgia Guaitoli, Stefania Pipitone, et al.. (2018). Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going. Cancer Management and Research. Volume 10. 91–103. 56 indexed citations
17.
18.
Toss, Angela, et al.. (2017). Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?. International Journal of Molecular Sciences. 18(1). 85–85. 32 indexed citations
19.
Podo, Franca, Filippo Santoro, Giovanni Di Leo, et al.. (2015). Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study. Clinical Cancer Research. 22(4). 895–904. 24 indexed citations
20.
Baviera, Marta, Irene Marzona, Fausto Avanzini, et al.. (2011). Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population‐based study. Diabetic Medicine. 29(3). 385–392. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Therese B. Bevers Breakdown of academic impact, for papers by Franco Lumachi Breakdown of academic impact, for papers by Reena S. Cecchini Breakdown of academic impact, for papers by Larissa A. Korde Breakdown of academic impact, for papers by William J. Huster Breakdown of academic impact, for papers by D Grady Breakdown of academic impact, for papers by Jonine L. Bernstein Breakdown of academic impact, for papers by Sara Wedrén Breakdown of academic impact, for papers by Matteo Puntoni Breakdown of academic impact, for papers by Christine D. Berg
Rankless by CCL
2026